Regulatory Agency / Academic Health Science Networks / Wellcome Trust / ABPI Stratified / UK Biobank / UK plc / /
Country
United Kingdom / /
Currency
pence / GBP / /
Event
Product Release / /
Facility
Christie Hospital / National Institute / Royal College of Pathologists / /
IndustryTerm
treatment of a number of cancers / pharmaceutical industry / integrated stakeholder healthcare strategy / identified / imaging / chemical base pairs / research-based biopharmaceutical / non-cancer stratified applications / healthcare system / healthcare professionals / non-cancer applications / treatment of breast cancer / Cancer applications / web-based questionnaire / /
MedicalCondition
particular disease / dementia / arthritis / rheumatoid arthritis / patient’s disease / advanced breast cancer / breast cancer / cancers / heart diseases / Cancer / disease / stroke / genetic diseases / tumour / diabetes / Alkaptonuria / diseases / osteoporosis / several stratified cancer / depression / /
Organization
National Phenome Centre / National Office for Clinical Research Infrastructure / UK Government / Medical Research Council / Association of the British Pharmaceutical Industry All / Interspecialty Committee on Molecular Pathology / Christie Hospital in Manchester / World Health Organisation / National Institute for Health Research / ABPI and RCPath / MHRA / Royal College of Pathologists / first national level phenome centre / NHS / International Society for Pharmacoeconomics and Outcomes Research / RCPath / /
Person
Ian Cree / Archibald Garrod / Sally C Davies / /
Position
Queen / President / Advisors / Chief Executive / FRCPath Chief Medical Officer and Chief Scientific Adviser Chair / leader / Professor / /
Product
Stratifying Disease / /
Technology
genomics / diagnostic tests / Human Genome / in vitro diagnostics / /
Stratified medicine in the NHS An assessment of the current landscape and implementation challenges for non-cancer applications